Dual Diagnosis Management

On this page

Dual Diagnosis Management: Definition & Scope - Double Trouble Basics

  • Definition: Co-occurrence of a Substance Use Disorder (SUD) and at least one other non-SUD psychiatric disorder (Mental Health Disorder, MHD).
  • AKA: Co-occurring Disorders (COD), Comorbidity.
  • Significance: "Double Trouble" - complicates diagnosis, treatment, prognosis; leads to ↑ relapse rates, ↓ treatment adherence, ↑ hospitalizations, poorer social outcomes.
  • Prevalence: High. Approx. 50% of individuals with severe mental disorders also have SUDs. Common in clinical settings.
  • Common Patterns:
    • SUD + Mood Disorders (e.g., Depression, Bipolar Disorder)
    • SUD + Anxiety Disorders (e.g., Panic Disorder, PTSD)
    • SUD + Psychotic Disorders (e.g., Schizophrenia)
    • SUD + Personality Disorders (e.g., ASPD)

⭐ Individuals with dual diagnosis often present with more severe symptoms, higher rates of medication non-adherence, increased risk of homelessness, and greater functional impairment compared to those with a single disorder.

Dual Diagnosis Management: Assessment Challenges - Spotting the Signs

Identifying dual diagnosis is complex due to overlapping and masked symptoms. A systematic approach is vital.

Loading diagram…
  • Spotting the Signs - Key Strategies:
    • Comprehensive History: Detailed substance use (type, amount, frequency, last use) and psychiatric history.
    • Temporal Relationship: Clarify onset of symptoms relative to substance use. Was it pre-existing?
    • Standardized Screening Tools:
      • Alcohol: AUDIT, CAGE
      • Drugs: DAST
      • Mental Health: MINI, PHQ-9, GAD-7
    • Collateral Information: From family, friends, previous records (with consent).
    • Observation During Abstinence: If feasible, helps differentiate substance-induced vs. primary disorder.

⭐ > Always consider substance intoxication or withdrawal as a differential for any acute psychiatric presentation.

Dual Diagnosis Management: Integrated Treatment - Unified Care Plan

  • Core Principle: Integrated treatment is gold standard; simultaneous care for SUD & psychiatric illness.
    • Managed by one multidisciplinary team or closely coordinated services for seamless care.
  • Unified Care Plan:
    • Single, comprehensive therapeutic plan for both disorders.
    • Patient-centered, shared decision-making.
    • Combines pharmacotherapy & evidence-based psychosocial interventions.
  • Key Elements:
    • Assertive outreach & sustained engagement.
    • Phased interventions: Engagement → Persuasion → Active Treatment → Relapse Prevention.
    • Long-term management; recovery-oriented.
    • Coordinated medication for both conditions.
    • Psychosocial therapies: MI, CBT, family therapy, skills training.
Loading diagram…

⭐ Integrated treatment shows superior outcomes (↓ substance use, ↓ psychiatric symptoms) vs. sequential/parallel models for dual diagnosis.

Dual Diagnosis Management: Specific Scenarios & Meds - Common Combos Care

  • Core Principles: Integrated treatment is vital. Address both disorders concurrently. Prioritize safety. Psychosocial therapies (CBT, MI) are essential.
  • Alcohol Use Disorder (AUD) + Depression/Anxiety:
    • Depression: SSRIs (e.g., Sertraline).
    • Anxiety: Buspirone, Hydroxyzine. Avoid Benzodiazepines (BZDs).
    • AUD: Naltrexone, Acamprosate.
  • Opioid Use Disorder (OUD) + Depression/Anxiety/PTSD:
    • OUD: Buprenorphine, Methadone (Opioid Agonist Therapy - OAT).
    • Mood/Anxiety: SSRIs/SNRIs. Mirtazapine (sleep/appetite).
    • ⚠️ Avoid BZDs with opioids (↑ respiratory depression risk).
  • Cannabis Use Disorder (CUD) + Psychosis (e.g., Schizophrenia):
    • Psychosis: Second-Gen Antipsychotics (SGAs) (e.g., Risperidone).
    • Crucial: Aggressively manage cannabis use.
  • Stimulant Use Disorder + Psychosis/Mania/Anxiety:
    • Psychosis: Antipsychotics.
    • Mania: Mood stabilizers (e.g., Valproate; monitor levels).
    • Anxiety: Non-BZD options.

⭐ Buprenorphine for OUD may exert antidepressant effects, potentially reducing antidepressant need in co-occurring depression.

High‑Yield Points - ⚡ Biggest Takeaways

  • Dual diagnosis: Co-occurrence of Substance Use Disorder (SUD) and another psychiatric illness.
  • Integrated treatment is superior, addressing both conditions simultaneously.
  • Always screen for both SUD and co-occurring mental illness.
  • Pharmacotherapy choices must consider drug interactions and efficacy for both disorders.
  • Psychosocial therapies (CBT, MI) are essential components of management.
  • ↑ risk of relapse, homelessness, suicide, and poorer treatment outcomes.
  • "No wrong door" policy ensures access to initial care or appropriate referral_._

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Dual Diagnosis Management

  1. 1. Which WHO-developed 10-item questionnaire screens for hazardous and harmful alcohol use?

    • A. FAST questionnaire
    • B. SADQ-C questionnaire
    • C. AUDIT questionnaire
    • D. CAGE questionnaire
    Show answer

    Answer: C. AUDIT questionnaire

    AUDIT is the WHO-developed 10-item questionnaire for screening hazardous and harmful alcohol use. FAST questionnaire is a four-item alcohol screening tool, not the WHO-developed 10-item AUDIT. SADQ-C questionnaire assesses the severity of alcohol dependence rather than serving as the requested WHO screening instrument. CAGE questionnaire is a four-item dependence-focused screening questionnaire, not the 10-item AUDIT.

  2. 2. Which drug has a dopamine-receptor action opposite to that of haloperidol?

    • A. Imipramine
    • B. Clozapine
    • C. Ropinirole
    • D. Pimozide
    Show answer

    Answer: C. Ropinirole

    Ropinirole - Ropinirole is a dopamine D2/D3 receptor agonist, whereas haloperidol blocks dopamine D2 receptors. - Their receptor actions oppose one another, but ropinirole is generally avoided for antipsychotic-induced parkinsonism because it may exacerbate psychosis and its effects are opposed by dopamine-receptor blockade. Imipramine - Imipramine primarily inhibits norepinephrine and serotonin reuptake as a tricyclic antidepressant, rather than directly opposing haloperidol’s dopamine D2 receptor blockade. - Its principal pharmacological actions do not produce a meaningful dopaminergic agonist–antagonist opposition to haloperidol. Clozapine - Clozapine is an atypical antipsychotic that retains dopamine-receptor antagonist activity, although its D2 affinity is lower than haloperidol’s. - Because both drugs provide antipsychotic dopamine antagonism, clozapine would not pharmacologically oppose haloperidol’s effects. Pimozide - Pimozide is a typical antipsychotic that blocks dopamine D2 receptors, similar to haloperidol’s principal mechanism. - Its shared D2 receptor antagonism would reinforce dopaminergic blockade rather than oppose haloperidol’s antipsychotic effects.

  3. 3. A 23-year-old woman has a lifelong fear of heights and avoids high-rise buildings. Moving her office to the tenth floor has caused occupationally impairing anxiety. Alprazolam provides temporary relief. What is the preferred definitive treatment?

    • A. Psychodynamic psychotherapy
    • B. Exposure therapy
    • C. Relaxation training
    • D. Supportive counseling
    Show answer

    Answer: B. Exposure therapy

    Exposure therapy is the preferred treatment for specific phobia because controlled exposure reduces fear and avoidance associated with heights. Psychodynamic psychotherapy does not provide the targeted exposure-based treatment preferred for this presentation. Relaxation training may reduce physiological anxiety but is not preferred as stand-alone definitive treatment. Supportive counseling may provide reassurance but does not systematically address avoidance of heights.

  4. 4. For core borderline personality disorder symptoms without a comorbid disorder requiring medication, which is the preferred treatment?

    • A. Combination of DBT and pharmacotherapy
    • B. Cognitive Behavioural Therapy (CBT)
    • C. Dialectical Behaviour Therapy (DBT)
    • D. Pharmacotherapy as sole treatment
    Show answer

    Answer: C. Dialectical Behaviour Therapy (DBT)

    Dialectical Behaviour Therapy (DBT) - DBT is the most evidence-based psychotherapy specifically developed for BPD, targeting emotional dysregulation, impulsivity, self-harm, and interpersonal difficulties. - It combines cognitive-behavioural techniques with mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness, with strong evidence for improving functioning and reducing suicidal behaviour. Combination of DBT and pharmacotherapy - DBT plus pharmacotherapy can be clinically useful when comorbid depression, anxiety, or severe mood instability requires additional symptom management. - It is not the best single answer because medications are adjunctive in BPD, whereas DBT remains the cornerstone treatment for core symptoms and personality pathology. Pharmacotherapy as sole treatment - Pharmacotherapy as sole treatment may reduce selected symptoms such as mood instability, impulsivity, or brief psychotic episodes. - No medication is specifically approved for BPD, and medication alone does not address the core personality pathology or interpersonal difficulties. Cognitive Behavioural Therapy (CBT) - CBT can help some BPD symptoms and comorbid depression or anxiety, but it was not specifically designed to address the full disorder. - DBT is a specialized adaptation of CBT with a broader focus on emotion regulation, distress tolerance, mindfulness, and interpersonal effectiveness.

  5. 5. Atomoxetine is used in the management of which of the following conditions?

    • A. Bipolar disorder
    • B. Schizophrenia
    • C. Attention-deficit/hyperactivity disorder
    • D. Major depressive disorder with melancholic features
    Show answer

    Answer: C. Attention-deficit/hyperactivity disorder

    Attention-deficit/hyperactivity disorder - Atomoxetine is a selective norepinephrine reuptake inhibitor primarily used to manage attention-deficit/hyperactivity disorder (ADHD). - As a non-stimulant, atomoxetine is useful when patients do not respond to or cannot tolerate stimulant medications, or when stimulant misuse is a concern. Major depressive disorder with melancholic features - Although atomoxetine affects norepinephrine, unlike venlafaxine or duloxetine it is not primarily indicated or established for treating major depressive disorder. - Major depressive disorder with melancholic features is treated with antidepressants such as selective serotonin reuptake inhibitors or approved serotonin–norepinephrine reuptake inhibitors, whereas atomoxetine is specifically used for ADHD. Bipolar disorder - Bipolar disorder is generally managed with mood stabilizers such as lithium or valproate and with certain antipsychotics, not atomoxetine. - Atomoxetine does not provide the mood-stabilizing effects required for bipolar disorder, even though ADHD symptoms may overlap with some mood-related symptoms. Schizophrenia - Schizophrenia is primarily treated with antipsychotic medications targeting dopamine and serotonin pathways; atomoxetine is not an indicated treatment. - Atomoxetine has no established efficacy against the positive or negative symptoms of schizophrenia, so it does not fit this diagnosis.

  6. 6. A woman presents with repetitive handwashing that she finds distressing and cannot resist. It interferes with her social life. Which behavioral treatment is most effective?

    • A. Exposure-response prevention
    • B. Systematic desensitization
    • C. Cognitive restructuring
    • D. Progressive muscle relaxation
    Show answer

    Answer: A. Exposure-response prevention

    Exposure-response prevention treats compulsive handwashing by exposing the patient to feared triggers while preventing the washing ritual. Cognitive restructuring can address dysfunctional beliefs but does not itself prevent the compulsive response. Systematic desensitization pairs graded exposure with relaxation and is not the specific response-prevention treatment required here. Progressive muscle relaxation may reduce arousal but does not directly interrupt the compulsive ritual.

  7. 7. All of the following can cause hypomagnesemia through renal magnesium wasting, EXCEPT:

    • A. Aminoglycoside
    • B. Furosemide
    • C. Cisplatin
    • D. Omeprazole
    Show answer

    Answer: D. Omeprazole

    Omeprazole Omeprazole causes hypomagnesemia primarily by reducing intestinal magnesium absorption rather than by increasing renal magnesium excretion. Aminoglycoside - Aminoglycosides can cause renal tubular damage, impairing magnesium reabsorption and producing increased urinary magnesium loss. - This nephrotoxicity makes aminoglycosides a cause of renal magnesium wasting and hypomagnesemia, so they do not fit the exception. Cisplatin - Cisplatin causes renal tubular toxicity, which can impair tubular magnesium reabsorption and increase urinary magnesium excretion. - The resulting renal magnesium loss may produce hypomagnesemia, so cisplatin is not the exception. Furosemide - Furosemide inhibits the Na-K-2Cl cotransporter in the thick ascending limb, reducing the transepithelial potential that supports magnesium reabsorption. - This promotes increased urinary magnesium excretion and hypomagnesemia, so furosemide is not the exception. Basis: Harrison’s Principles of Internal Medicine, disorders of magnesium, distinguishes gastrointestinal magnesium depletion from renal magnesium wasting. Liamis G et al. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacology Research & Perspectives. 2021;9:e00829 describes proton-pump inhibitors as predominantly impairing gastrointestinal magnesium absorption and loop diuretics, aminoglycosides and cisplatin as causes of renal magnesium loss.

  8. 8. Headache, behavioural changes, schizophrenia-like psychosis, visual hallucinations, and paranoia develop after repeated high-dose use of a stimulant prescribed for attention-deficit/hyperactivity disorder. Which substance is implicated?

    • A. Cocaine
    • B. Cannabis
    • C. Amphetamine
    • D. Diamorphine
    Show answer

    Answer: C. Amphetamine

    Amphetamine is implicated because the symptoms follow misuse of a stimulant prescribed for attention-deficit/hyperactivity disorder. Diamorphine is an opioid that typically causes sedation, miosis, and respiratory depression rather than this stimulant syndrome. Cocaine can cause the same psychotic symptoms, but it is not the prescribed attention-deficit/hyperactivity disorder stimulant described here. Cannabis can cause paranoia or psychosis, but it does not fit the stated prescribed-stimulant exposure

  9. 9. Which drug is NOT an established treatment for the core symptoms of OCD?

    • A. Fluoxetine
    • B. Sertraline
    • C. Clomipramine hydrochloride
    • D. Carbamazepine
    Show answer

    Answer: D. Carbamazepine

    Carbamazepine is not an established treatment for the core symptoms of OCD. Fluoxetine is an SSRI with established efficacy in OCD. Sertraline is another SSRI used as first-line pharmacotherapy for OCD. Clomipramine hydrochloride is an effective serotonin reuptake inhibitor generally considered after SSRIs because of its less favourable adverse-effect profile.

  10. 10. Ekbom's syndrome is commonly associated with which of the following conditions?

    • A. Cocaine intoxication
    • B. Opioid intoxication
    • C. Benzodiazepine intoxication
    • D. Barbiturate intoxication
    Show answer

    Answer: A. Cocaine intoxication

    Cocaine intoxication is the best answer because increased dopaminergic activity can produce formication and secondary delusional infestation. Opioid intoxication typically causes sedation, miosis, and respiratory depression rather than this characteristic stimulant-associated presentation. Benzodiazepine intoxication typically causes sedation and ataxia rather than delusional infestation. Barbiturate intoxication causes dose-dependent central nervous system and respiratory depression rather than the characteristic cocaine-associated infestation phenomenon.

Flashcards: Dual Diagnosis Management

  1. 1. Cannabis can cause dependence

    Show answer

    physical and psychological (physical/psychological)

  2. 2. _____ hallucinations are common in _____ withdrawal and stimulant use (e.g. cocaine, amphetamines)

    Show answer

    Tactile · alcohol

  3. 3. is a 10-item screening tool developed by the WHO to assess alcohol consumption, drinking behaviors, and alcohol-related problems

    Show answer

    Alcohol Use Disorders Identification Test (AUDIT)

  4. 4. The  questionnaire is a 4 question screening for alcohol problems.

    Show answer

    CAGE

  5. 5. What is the treatment for PCP intoxication? _____, _____

    Show answer

    Benzodiazepines · rapid-acting antipsychotics

  6. 6. _____ syndrome is a late manifestion of Wernicke encephalopathy characterized by _____, irreversible memory loss, and personality changes

    Show answer

    Korsakoff · confabulations

  7. 7. Non-specific symptoms of alcohol withdrawal, such as anxiety, insomnia, and tremors, typically occur after _____ - _____ hours

    Show answer

    6 · 36

  8. 8. The alcoholic hallucinosis of alcohol withdrawal usually occurs _____ to _____ hours after the last drink

    Show answer

    12 · 48

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF